ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $21,168,000 | +216.3% | 456,900 | +66.4% | 0.06% | +210.5% |
| Q1 2019 | $6,692,000 | +124.5% | 274,500 | +31.2% | 0.02% | +90.0% |
| Q4 2018 | $2,981,000 | -5.6% | 209,200 | +0.7% | 0.01% | +11.1% |
| Q3 2018 | $3,157,000 | -9.4% | 207,700 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $3,485,000 | +6.5% | 207,700 | +3.6% | 0.01% | +11.1% |
| Q1 2018 | $3,271,000 | +51.2% | 200,400 | +18.5% | 0.01% | +50.0% |
| Q4 2017 | $2,164,000 | +37.5% | 169,100 | +32.1% | 0.01% | +20.0% |
| Q3 2017 | $1,574,000 | +47.0% | 128,000 | 0.0% | 0.01% | +66.7% |
| Q2 2017 | $1,071,000 | -59.7% | 128,000 | -85.8% | 0.00% | -70.0% |
| Q1 2016 | $2,655,000 | -16.1% | 900,000 | +20.0% | 0.01% | -16.7% |
| Q4 2015 | $3,165,000 | -44.5% | 750,000 | -40.0% | 0.01% | -45.5% |
| Q3 2015 | $5,700,000 | +12.9% | 1,250,000 | +78.6% | 0.02% | +22.2% |
| Q2 2015 | $5,047,000 | -2.2% | 700,000 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $5,159,000 | +9.1% | 700,000 | -30.0% | 0.02% | +12.5% |
| Q4 2014 | $4,730,000 | +69.0% | 1,000,000 | +122.2% | 0.02% | +33.3% |
| Q3 2013 | $2,799,000 | +37.0% | 450,000 | 0.0% | 0.01% | +33.3% |
| Q2 2013 | $2,043,000 | – | 450,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|